Cargando…
The β3 Adrenergic Receptor Agonist CL316243 Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats by Activating AMPK/PGC-1α Signaling in Skeletal Muscle
PURPOSE: Skeletal muscle has a major influence on whole-body metabolic homeostasis. In the present study, we aimed to determine the metabolic effects of the β3 adrenergic receptor agonist CL316243 (CL) in the skeletal muscle of high-fat diet-fed rats. METHODS: Sprague-Dawley rats were randomly alloc...
Autores principales: | Ding, Li-Na, Cheng, Ya, Xu, Lu-Yao, Zhou, Le-Quan, Guan, Li, Liu, Hai-Mei, Zhang, Ya-Xing, Li, Run-Mei, Xu, Jin-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987271/ https://www.ncbi.nlm.nih.gov/pubmed/33776460 http://dx.doi.org/10.2147/DMSO.S297351 |
Ejemplares similares
-
CL316,243, a β3-adrenergic receptor agonist, induces muscle hypertrophy and increased strength
por: Puzzo, Daniela, et al.
Publicado: (2016) -
Apparent histological changes of adipocytes after treatment with CL 316,243, a β-3-adrenergic receptor agonist
por: Ghorbani, Masoud, et al.
Publicado: (2015) -
Anti-obesity and metabolic efficacy of the β3-adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22°C
por: Xiao, Cuiying, et al.
Publicado: (2015) -
Anti Diabetic effect of CL 316,243 (A β3-Adrenergic Agonist) by Down Regulation of Tumour Necrosis Factor (TNF-α) Expression
por: Ghorbani, Masoud, et al.
Publicado: (2012) -
The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice
por: Kumar, Amit, et al.
Publicado: (2015)